ScreenProt: Screening Protocol for Research Participants
Study Details
Study Description
Brief Summary
The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The MPRC/NIDA collaborative research program attempts to: elucidate the nature of serious mental illnesses, drug abuse and addiction; determine the potential use of new therapies, both pharmacological and psychosocial; and decipher the long-term effects of drugs of abuse on the development, maturation, function, and structure of the brain and other organ systems. In support of this work, the scientific goal of this screening protocol is to assess potential research participants' eligibility for research studies. Screening will include medical and psychological tests and procedures. The data collected during screening are a unique and valuable source of information that aids in the research mission. Therefore, a secondary goal of this protocol is to obtain data that characterizes the population of subjects contacting NIDA about research participation and to analyze data so obtained, such as that on the prevalence and consequences of HIV/AIDS, viral hepatitis, and related diseases and issues of selection and sample bias in clinical research.
The screening process will be done in two stages, a telephone interview and an in-person evaluation. The telephone interview will last approximately 20 minutes and be conducted solely via the NIDA call center. Answers provided during the phone interview will indicate whether a caller is eligible for in-person screening. Those who appear eligible will be given an appointment at either NIDA or MPRC. This protocol pertains only to the in-person participants at MPRC. Written informed consent will be obtained when the person arrives. The screening process can involve up to 5 visits to MPRC.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Screening Screening Assessment battery. Specific to study(or studies) the individual is screening for. |
Behavioral: Various Screening psychiatric and medical assessments
Possibly blood draws, urine samples, toxicology screens, computer-based and written psychological, psychiatric, and behavioral questionnaires and assessments.
|
Outcome Measures
Primary Outcome Measures
- Recruitment of participants into NIDA/MPRC protocols. [5 years]
Secondary Outcome Measures
- Demographic characterization of drug users, non-users, and individuals with serious mental illnesses contacting NIDA/MPRC about research participation [5 year]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 18 or older
-
Ability to read and understand and answer questions posed.
Exclusion Criteria:
-
Inability to provide valid informed consent
-
Below Age 18, and above age 64.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Maryland Psychiatric Research Center | Catonsville | Maryland | United States | 21228 |
Sponsors and Collaborators
- University of Maryland, Baltimore
Investigators
- Principal Investigator: Deanna L Kelly, Pharm.D., BCPP, University of Maryland, College Park
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- HP-00043664
- MPRC #412
- NIDA #444